Triple Therapy Halved the Risk of Death Among Patients Hospitalized With Severe COVID-19
Rutgers University-New BrunswickAdding baricitinib to remdesivir and dexamethasone improved outcomes among patients hospitalized with Covid-19, according to a Rutgers researcher